Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Sale of 147,059 SEPN shares, $7.39M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Septerna, Inc. (SEPN) | Sale | 147,059 | $7.39M |
| May 28, 2026 | Rapport Therapeutics, Inc. (RAPP) | Sale | 18,572 | $743.8K |
| May 13, 2026 | Rapport Therapeutics, Inc. (RAPP) | Sale | 133,618 | $5.38M |
| May 11, 2026 | Rapport Therapeutics, Inc. (RAPP) | Sale | 271,495 | $10.89M |
| Apr 21, 2026 | Rapport Therapeutics, Inc. (RAPP) | Sale | 426,005 | $17.18M |
| Nov 5, 2025 | Maze Therapeutics, Inc. (MAZE) | Other (see footnotes) | 1,600,000 | n/a |
| Feb 26, 2025 | Septerna, Inc. (SEPN) | Purchase | 18,861 | $113.1K |
| Feb 24, 2025 | Septerna, Inc. (SEPN) | Purchase | 612,674 | $3.63M |
| Feb 4, 2025 | Maze Therapeutics, Inc. (MAZE) | Conversion | 5,762,788 | n/a |
| Oct 28, 2024 | Septerna, Inc. (SEPN) | Conversion | 4,790,773 | n/a |